{"editorial":{"content_id":"bd9005aa-ac3b-4fa4-b866-d06fd3e18086","slug":"glp-20261114-7f6153","content_type":"news","title":"巴西GLP-1搜索量一年增138.5%，远超线上药房流量增速","summary":"Similarweb数据显示，2025年8月至2026年8月巴西GLP-1相关搜索量从每月94.3万次增至225万次，增长138.5%，增速远高于线上药房流量的15.7%。","body":"据Similarweb对巴西桌面端和移动端网页数据的调查，2025年8月至2026年8月，巴西与GLP-1相关的搜索量从每月94.3万次增至225万次，增长138.5%，增速高于同期线上药房流量的15.7%（从3510万次访问增至4060万次）。\n\n调查显示，消费者搜索词结构也在变化：分子和活性成分的搜索从每月9.48万次增至82.94万次，增长775%；商业品牌搜索从84.86万次增至142万次，增长67.3%。\n\n2026年8月的主要搜索词中，Mounjaro为80.29万次，tirzepatida为61.02万次，Ozivy为20.35万次，Semaglutida为19.42万次，Ozempic为18.25万次，Wegovy为11.21万次。\n\nSimilarweb洞察负责人Vicky Almeida表示，需求增长快于线上药房流量，形成意图与需求捕获之间的缺口，理解受众停留在哪里可能为品牌和零售商带来机会。研究还显示，83%的搜索为信息性搜索，16%具有交易意图，仅1%为品牌搜索，超过80%的搜索最终没有点击。Vicky Almeida称，品类和活性成分主导了这一旅程，为品牌在发现阶段切入留出空间。\n\n在需求捕获环节，四家药房连锁集中了GLP-1十大目的地中66.8%的点击量，包括Drogaria São Paulo、Pague Menos、Drogasil和Droga Raia。2026年8月，Drogasil获得9.65万次点击，Drogaria São Paulo为7.77万次，Lilly为8100次，Novo Nordisk为7500次。Pague Menos的Mounjaro页面获得153万次自然点击，Drogasil的Ozempic页面获得102万次。\n\n导航还涉及患者支持项目（PSP）和电商：NovoDia的访客中，34%也访问了Drogasil，32%访问Droga Raia，25%访问Pague Menos。除零售和PSP外，社交网络也出现在该品类相关点击的目的地中。","why_it_matters":null,"cbi_observation":null,"direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["行业趋势","市场进入","br-health"],"content_level":"编辑整理","event_type":"行业趋势","audience_tags":[],"event_location":null,"verification_status":"unverified","published_at":"2026-11-14T11:02:35.721Z","display_date":"2026-11-14","source_published_at":null,"source_url":"https://panoramafarmaceutico.com.br/busca-por-glp-1-cresce-1385-no-brasil/","source_name":"Panorama Farmacêutico","source_language":"pt","author_name":"编辑部","risk_level":"medium","risk_flags":[],"opportunity_flags":[],"trend_signals":[]},"intelligence":null,"meta":{"canonical_url":"https://chinabrazilinsight.com/news/glp-20261114-7f6153","api_url":"https://chinabrazilinsight.com/api/public/content/glp-20261114-7f6153","markdown_url":"https://chinabrazilinsight.com/api/public/content/glp-20261114-7f6153?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/glp-20261114-7f6153?view=json","last_updated":"2026-11-14T11:02:58.679Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}